Medical Device Security Market: as the FDA's Quality Management System Regulation folds cybersecurity risk management directly into device quality systems and healthcare cyber incidents surge past insurers' underwriting tolerance, platform consolidation among visibility vendors is accelerating faster than the underlying connected device installed base itself, so scale in device protocol coverage is becoming as commercially decisive as detection accuracy.

The global medical device security market size was USD 9.11 Billion in 2025 and is expected to register a revenue CAGR of 8.8% during the forecast period.Market revenue growth is driven by factors such as expanding connected medical device deployments across hospital networks, escalating frequency and severity of ransomware attacks targeting healthcare institutions with legacy device infrastructure, and tightening regulatory requirements folding cybersecurity risk management directly into device quality systems.The first driving factor is the sheer scale of connected medical device deployment across hospital networks. A large hospital can manage between 10,000 and 25,000 connected medical devices, which may account for 30 to 40% of all networked endpoints in clinical environments.The second driving factor is escalating ransomware and cyberattack frequency against healthcare institutions with legacy device infrastructure. Health-ISAC reported a 55% surge in cyber incidents targeting healthcare in 2025, with ransomware as the leading threat.The third driving factor is tightening regulatory requirements folding cybersecurity risk management directly into device quality systems, exemplified by the FDA's Quality Management System Regulation requiring cybersecurity risk management to integrate with manufacturer quality systems under ISO 13485.These are some of the key factors driving revenue growth of the market.

A second layer of demand comes from the way a security platform's device protocol signature library widens its addressable hospital footprint every time it adds coverage for another device type, which converts a single hospital deployment into a broader, more defensible installed base without requiring the vendor to win an entirely new category of customer.Once a visibility platform's protocol library covers a new class of legacy or specialty medical device, that coverage becomes immediately sellable to every hospital in the vendor's existing pipeline running that device type, so platform revenue compounds as protocol coverage breadth grows rather than requiring proportional growth in the underlying connected device count.As a result, demand and revenue share are concentrating around platforms with the broadest device protocol coverage and largest device behavior knowledge bases, that hold the deepest clinical-context risk scoring capability, and the forecast tilts toward these platform consolidators rather than narrow point solutions covering a single device category.For instance, in December 2025, ServiceNow announced a definitive agreement to acquire Armis for USD 7.75 Billion, with the deal expected to close in the second half of 2026, following Axonius's completed acquisition of Cynerio for over USD 100 Million in July 2025, together signalling that platform consolidation is proceeding faster than the underlying connected device installed base itself is growing.These are some of the key factors driving revenue growth of the market.

Because legacy medical devices running end-of-life operating systems cannot be patched to address known vulnerabilities, these devices must be managed through compensating network segmentation and monitoring controls rather than direct remediation, creating persistent unresolvable residual security risk that conventional IT endpoint security tools cannot address.

Healthcare institution budget prioritisation is a second constraint, because medical device security funding competes with higher-visibility clinical equipment procurement and electronic health record upgrades at annual budget allocation cycles.

Deployment complexity is a third constraint, since active security scanning risks disrupting delicate legacy clinical equipment, requiring passive, agentless discovery approaches that add engineering overhead relative to conventional enterprise IT security tools.

These factors substantially limit medical device security market growth over the forecast period.

The clearest driver of demand is the scale mismatch between connected device growth and hospitals' ability to secure that growing fleet with conventional IT security tools. A hospital only invests in dedicated medical device security infrastructure once conventional enterprise IT tools genuinely cannot cover the device fleet, and connected medical devices, which cannot run standard endpoint security agents and often run unsupported legacy operating systems, create exactly that coverage gap. A large hospital can manage between 10,000 and 25,000 connected medical devices, accounting for 30 to 40% of all networked endpoints in clinical environments, while Health-ISAC reported a 55% surge in cyber incidents targeting healthcare in 2025, with ransomware as the leading threat. According to Claroty Team82's State of CPS Security: Healthcare Exposures 2025 report, 89% of healthcare organizations operate connected medical devices with known exploitable vulnerabilities, and the IBM Cost of a Data Breach Report 2025 found healthcare breaches cost an average of USD 7.42 Million per incident, the highest of any industry for the 14th consecutive year. The effect on the market is that hospital cybersecurity budgets are increasingly allocating dedicated line items specifically for medical device visibility and protection, separate from general IT security spending. These are some of the key factors driving revenue growth of the market.

The second driver is the regulatory shift from treating cybersecurity as a one-time premarket submission requirement to an ongoing quality system obligation spanning a device's entire commercial life. A manufacturer only maintains continuous cybersecurity documentation if the regulatory framework requires it as an ongoing quality system function, and the FDA's Quality Management System Regulation does exactly that by folding cybersecurity risk management directly into ISO 13485-aligned quality processes rather than treating it as a discrete premarket deliverable. The FDA's updated cybersecurity guidance, finalized in June 2025 and revised in March 2026, treats cybersecurity documentation as a prerequisite for market authorization, with the FDA able to refuse premarket submissions that fall short of Section 524B requirements. On May 29, 2025, Medcrypt launched its Medical Device Product Security Intelligence Platform, designed to help manufacturers assess security risks, identify gaps, quantify cybersecurity risk in dollar terms, and generate cost-aligned remediation plans for both premarket and postmarket compliance teams. The effect on the market is that manufacturers are shifting cybersecurity spending from a one-time premarket cost centre into a recurring quality system line item, sustaining demand for continuous risk assessment and documentation platforms. These are some of the key factors driving revenue growth of the market.

“According to Claroty Team82's State of CPS Security: Healthcare Exposures 2025 report, 89% of healthcare organizations operate connected medical devices with known exploitable vulnerabilities, while the average healthcare data breach now costs USD 7.42 Million, the highest of any industry.”

The third driver is the emergence of cyber insurance economics as an independent commercial justification for medical device security investment, separate from regulatory compliance requirements. A hospital only accelerates security investment beyond the regulatory minimum if there is a direct, quantifiable financial return, and cyber insurers now assessing segmentation maturity during underwriting, with premium reductions averaging 15 to 30% for organizations that improve their segmentation posture, provide exactly that direct financial return. Approximately 75% of cyber insurers now assess segmentation maturity during underwriting, and for a health system paying USD 2 to 5 Million in annual cyber insurance premiums, improved segmentation can directly offset the cost of new security tooling. The proposed HIPAA Security Rule updates expected in 2026 will reclassify network segmentation from an addressable recommendation to a required control, further reinforcing the insurance-driven investment case with a regulatory backstop. The effect on the market is that medical device security investment decisions are increasingly justified on direct insurance premium return-on-investment grounds, expanding the buyer base beyond compliance-driven security teams to hospital financial leadership. These are some of the key factors driving revenue growth of the market.

However, the medical device security market faces severe adoption constraints from unpatchable legacy device infrastructure, healthcare institution budget prioritisation challenges, and deployment complexity.

Because legacy medical devices including imaging systems, infusion pumps, and patient monitoring equipment running end-of-life operating systems cannot be patched to address known vulnerabilities, these devices must be managed through compensating network segmentation and monitoring controls rather than direct device remediation, creating persistent unresolvable residual security risk that conventional IT endpoint security solutions cannot address at the clinical device network management level.

Healthcare institution budget prioritisation compounds this, because medical device security funding competes with higher-visibility clinical equipment procurement, electronic health record upgrades, and facility infrastructure investment at annual budget allocation cycles, particularly at smaller community hospital and ambulatory surgical centre accounts where security investment sophistication lags large academic medical centre deployment levels.

Deployment complexity is the third constraint, since active security scanning risks disrupting delicate legacy clinical equipment during scanning, requiring passive, agentless discovery approaches with sufficient device protocol signature libraries to avoid triggering false alarms or crashing sensitive equipment, so vendors without mature protocol coverage cannot safely deploy across a hospital's full legacy device fleet.

These factors substantially limit medical device security market growth over the forecast period.

Based on component, the global medical device security market is segmented into solutions and services. Solutions hold the largest revenue share at approximately 62% of 2025 revenue, because IAM, encryption, antivirus, IDS/IPS, risk and compliance management, and DDoS protection software form the core technology layer every hospital security deployment ultimately requires. Services are expected to register the fastest revenue growth rate over the forecast period, driven by hospitals requiring ongoing consulting, implementation, and managed security services to operate increasingly complex multi-vendor security architectures.

Based on solution type, the global medical device security market is segmented into IAM, encryption, antivirus and antimalware, IDS/IPS, risk and compliance management, and disaster recovery/DDoS solutions. IAM solutions hold the largest solution revenue share, reflecting the foundational role of identity verification and access control in preventing unauthorised access to clinical device networks. Risk and compliance management, encompassing SBOM and vulnerability management, is expected to register the fastest revenue growth rate, driven by the FDA's Quality Management System Regulation and expanding SBOM documentation requirements at platforms including Medcrypt and Claroty.

Based on end-use, the global medical device security market is segmented into hospitals and hospital medical devices, medical device manufacturers, and independent software vendors and healthcare IT companies. Hospitals and hospital medical devices hold the largest revenue share, reflecting the concentration of the connected device installed base at hospital networks managing thousands of heterogeneous clinical devices. Medical device manufacturers are expected to register the fastest revenue growth rate, driven by the FDA's premarket cybersecurity documentation requirements pushing OEMs toward dedicated security intelligence platforms including Medcrypt earlier in the device development cycle.

Based on regional analysis, the medical device security market in North America accounted for largest revenue share in 2025. The United States leads because the FDA's Cyber Device provisions and Quality Management System Regulation create binding regulatory compliance deadlines, and because the country hosts the headquarters of Claroty, Armis, Asimily, and Ordr, the largest medical device security platforms serving the US hospital base. The IBM Cost of a Data Breach Report 2025 found healthcare breaches cost an average of USD 7.42 Million per incident in the United States, the highest of any industry, reinforcing the domestic commercial case for security investment. The concentration of leading security platform vendors in the United States also means new protocol coverage and detection capabilities are often developed and piloted domestically before being extended to other regions.

The market in Europe is expected to register a steady revenue growth rate over the forecast period. Germany, the United Kingdom, France, and the Netherlands represent the four largest national markets, with GDPR and EU MDR cybersecurity requirements driving sustained hospital security investment. The EU Cyber Resilience Act's mandatory vulnerability reporting requirement, beginning September 11, 2026, is creating a new compliance deadline, but fragmented national implementation timelines and hospital-by-hospital digital maturity variation create uneven adoption pacing across the region. The result is steady rather than rapid growth, shaped more by phased regulatory implementation timing than by underlying threat exposure.

The market in Asia Pacific is expected to register the fastest revenue growth rate over the forecast period at approximately 9.51% CAGR, driven by China, Japan, South Korea, and India's expanding hospital digitisation and connected device installed base. Singapore's Global Digital Health Partnership guidance for medical device cybersecurity is establishing a regional framework that other Asia Pacific markets are increasingly adopting as a reference standard. This leaves more room for growth than in the more mature North American and European security markets, where hospital-vendor relationships are already largely established.

The market in Latin America is expected to register a moderate revenue growth rate over the forecast period. Brazil and Mexico represent the two largest national markets, with hospital cybersecurity investment concentrated at private hospital networks in São Paulo and Mexico City. Iran-US sanctions continue to disrupt freight and import costs for the specialised networking appliances and security hardware that Latin American hospital systems depend on to deploy device visibility platforms, with cargo rerouting around the Strait of Hormuz corridor raising landed equipment costs and slowing security infrastructure expansion beyond the region's main hospital networks through 2026.

The market in Middle East and Africa is expected to register a moderate revenue growth rate over the forecast period. Saudi Arabia and the UAE represent the primary GCC commercial markets, with the Saudi Vision 2030 healthcare digitisation programme driving new demand for hospital cybersecurity infrastructure. The UAE is the most established market on the continent for hospital cybersecurity infrastructure, while the Gulf states more broadly are still building dedicated medical device security capability largely from scratch.